<SEC-DOCUMENT>0001640334-25-000146-index.html : 20250122 <SEC-HEADER>0001640334-25-000146.hdr.sgml : 20250122 <ACCEPTANCE-DATETIME>20250122160621 ACCESSION NUMBER: 0001640334-25-000146 CONFORMED SUBMISSION TYPE: S-3 PUBLIC DOCUMENT COUNT: 7 FILED AS OF DATE: 20250122 DATE AS OF CHANGE: 20250122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lexaria Bioscience Corp. CENTRAL INDEX KEY: 0001348362 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 202000871 STATE OF INCORPORATION: NV FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: S-3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-284407 FILM NUMBER: 25545978 BUSINESS ADDRESS: STREET 1: 100 - 740 MCCURDY ROAD CITY: KELOWNA STATE: A1 ZIP: V1X 2P7 BUSINESS PHONE: 250-765-6424 MAIL ADDRESS: STREET 1: 100 - 740 MCCURDY ROAD CITY: KELOWNA STATE: A1 ZIP: V1X 2P7 FORMER COMPANY: FORMER CONFORMED NAME: LEXARIA CORP. DATE OF NAME CHANGE: 20080229 FORMER COMPANY: FORMER CONFORMED NAME: Lexaria Corp. DATE OF NAME CHANGE: 20051229 </SEC-HEADER> <DOCUMENT> <TYPE>S-3 <SEQUENCE>1 <FILENAME>lxrp_s3.htm <DESCRIPTION>S-3 <TEXT> Document 1 - file: lxrp_s3.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>lxrp_ex51.htm <DESCRIPTION>OPINION <TEXT> Document 2 - file: lxrp_ex51.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>lxrp_ex231.htm <DESCRIPTION>CONSENT <TEXT> Document 3 - file: lxrp_ex231.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>4 <FILENAME>lxrp_ex107.htm <DESCRIPTION>FEE TABLE <TEXT> Document 4 - file: lxrp_ex107.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>lxrp_ex51img1.jpg <TEXT> Document 5 - file: lxrp_ex51img1.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>lxrp_s3img1.jpg <TEXT> Document 6 - file: lxrp_s3img1.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>lxrp_s3img2.jpg <TEXT> Document 7 - file: lxrp_s3img2.jpg
</DOCUMENT> </SEC-DOCUMENT>